BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 30, 2001
View Archived Issues
Graft material for oral mucosal defects
Read More
Orion and Pharmacia agree to develop antianxiety treatment for the U.S. market
Read More
CollaGenex to market dental products from Atrix in the U.S.
Read More
CV Therapeutics and Incyte advance cardiovascular genomics collaboration
Read More
Avant replies to FDA's clinical hold of TP-10
Read More
Novel inhibitors of human CD23 and TNF release reported by GSK
Read More
Four centers added to Neotrofin Parkinson's disease trial
Read More
PH-10 enters phase I study for treatment of actininc keratosis
Read More
OSI Pharmaceuticals updates Tarceva development
Read More
Exisulind reduces adenomatous colon polyps in clinical trial
Read More
Virax to develop prostate cancer immunotherapy
Read More
More data reported for BMP delivery systems
Read More
Adult skin as a source of multipotent stem cells
Read More
NeoGenesis to develop drug leads for Mitsubishi-Tokyo Pharmaceuticals
Read More
BTG takes over development of oral vaccine delivery technology
Read More
Affymetrix and Orchid broaden genetic technology alliance
Read More
Positive phase II results reported for PhotoCure's Hexvix diagnostic
Read More
Pharmacia presents antiherpesvirus agents with outstanding activity at ACS
Read More
Corgentech cleared by FDA to begin phase III trial of E2F decoy
Read More
NeuroSearch cleared to begin phase I studies of potential sickle cell disease treatment in U.S.
Read More
ImmunoGen highlights significant events over past year
Read More
GSK describes NPY Y5 antagonists and their effect on food intake
Read More
Banyu describes first M3 antagonist with high selectivity over other muscarinic subtypes
Read More
Meiji Seika discloses new antineoplastics isolated from fungus
Read More
Dual angiotensin/endothelin receptor antagonists reported by BMS
Read More
CRF antagonists added to DuPont patent portfolio
Read More
Research at Nippon Shinyaku leads to new antitumor compounds
Read More
Novel DMARDs reported by Sumitomo during the ACS meeting
Read More